Revance Therapeutics, Inc. (37) | Services Agreements (1)

Recent Contracts

Amendment No. 1 to the Technology Transfer, Validation and Commercial Fill/Finish Services Agreement dated December 18, 2020 between Revance Therapeutics, Inc. and Ajinomoto... (Filed With SEC on February 25, 2021)